Genomenon Inc.
PrivateLast Round
Early Funding
Jul 30, 2026
Total Funding Raised
$33.1M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Genomenon Inc. is an AI-driven genomics company that provides software, data, and services for genomic information analysis to support clinical and pharmaceutical organizations.
Sector
Healthcare & Life Sciences
Verticals
Precision Medicine, Healthcare Analytics, Medical AI, Drug Discovery, Biotechnology
Business Model
B2B
Customer Profile
Subscription SaaS, Data as a Service, Services & Consulting, Freemium, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Genomenon Inc. Comparables
Compare Genomenon Inc. with similar companies based on industry and business-model similarity.
Genomenon Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Jul 30, 2026 | ||||
| Series B | Mar 10, 2022 | ||||
| Grant | Feb 15, 2022 | ||||
| Series A | Mar 16, 2021 | ||||
| Seed | Jan 8, 2019 | ||||
Grant | Apr 25, 2017 |
Key People
Founding team and executive leadership
Genomenon Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Invest Detroit | Seed |
| NIH RADx | Grant |
| Monroe-Brown Foundation | Seed |
| University of Michigan | Series B |
| Beringea | Series B |
| Ann Arbor SPARK | Series A, Series B, Seed |
| Michigan Investment in New Technology Startups | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 30, 2026
Raised $6M in seed funding.
- Jan 22, 2026
Monthly visitors increased 45% MoM, reaching 32.8K.
Genomenon Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Genomenon Inc.'s valuation, stock price, and market status.
Is Genomenon Inc. a public or private company?
Genomenon Inc. is a private company.
What is the current stock price of Genomenon Inc.?
Genomenon Inc. is a private company with no public stock price. No recent secondary market data is available.
How much is Genomenon Inc. worth (valuation)?
Valuation information for Genomenon Inc. is not publicly available.
Can I buy Genomenon Inc. stock?
Genomenon Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Genomenon Inc.'s last funding round?
Genomenon Inc.'s most recent funding round was Series B on March 10, 2022.
Who are the main investors in Genomenon Inc.?
Key investors in Genomenon Inc. include Beringea, Spring Mountain Capital, BroadOak Capital Partners.
Will Genomenon Inc. IPO soon?
No public IPO plans have been announced for Genomenon Inc..
How can I track Genomenon Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Genomenon Inc.'s secondary market activity and sign up for updates.